|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1996-12-5
|
|
pubmed:abstractText |
Nevirapine is a non-nucleoside reverse transcriptase inhibitor of HIV-1 which exhibits synergy in vitro with zidovudine (ZDV) and also is active against ZDV-resistant HIV. We evaluated the activity and safety of nevirapine in combination with ZDV in patients receiving long-term ZDV therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
635-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8780818-Adult,
pubmed-meshheading:8780818-Anti-HIV Agents,
pubmed-meshheading:8780818-Drug Therapy, Combination,
pubmed-meshheading:8780818-Female,
pubmed-meshheading:8780818-HIV Core Protein p24,
pubmed-meshheading:8780818-HIV Infections,
pubmed-meshheading:8780818-HIV-1,
pubmed-meshheading:8780818-Humans,
pubmed-meshheading:8780818-Male,
pubmed-meshheading:8780818-Nevirapine,
pubmed-meshheading:8780818-Pyridines,
pubmed-meshheading:8780818-Zidovudine
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients. The Dutch-Italian-Australian Nevirapine Study Group.
|
|
pubmed:affiliation |
HIV Medicine Unit, St. Vincent's Hospital, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
